2019, Número 3
<< Anterior Siguiente >>
Rev Hosp Jua Mex 2019; 86 (3)
Hemangioblastoma espinal extradural
Lomelí-Ramírez JJ, Pérez-Barrera AGS, Rivero-Rejón A, Lomelí-Canavaggio MN
Idioma: Español
Referencias bibliográficas: 25
Paginas: 145-149
Archivo PDF: 190.04 Kb.
RESUMEN
Introducción: Los hemangioblastomas espinales son neoplasias benignas de incidencia poco frecuente. Se caracterizan por ser generalmente asintomáticos y su progresión clínica depende de su tamaño y expansión, lo que aumenta la morbilidad.
Caso clínico: El caso descrito a continuación, paciente femenino de 83 años, es relevante por la presentación clínica y radiológica, su escasa frecuencia en la población adulta, así como su importancia por las comorbilidades asociadas.
Conclusiones: El hemangioblastoma espinal representa un porcentaje menor de las neoplasias espinales, su diagnóstico es incidental y el cuadro clínico se determina por su ubicación.
REFERENCIAS (EN ESTE ARTÍCULO)
dos Santos MP, Zhang J, Ghinda D, Glikstein R, Agid R, Rodesch G, et al. Imaging diagnosis and the role of endovascular embolization treatment for vascular intraspinal tumors. Neurosurg Focus 2015; 39: E16.
Chung SY, Jeun SS, Park JH. Disseminated hemangioblastoma of the central nervous system without von Hippel-Lindau disease. Brain Tumor Res Treat 2014; 2: 96-101.
Deng X, Wang K, Wu L, Yang C, Yang T, Zhao L, et al. Intraspinal hemangioblastomas: analysis of 92 cases in a single institution: clinical article. J Neurosurg Spine 2014; 21: 260-9.
Aldape KD, Plate KH, Vortmeyer AO, et al. Haemangioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, et al, eds. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press; 2007. pp. 184-6.
Shankar GM, Taylor-Weiner A, Lelic N, Jones RT, Kim JC, Francis JM, et al. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun 2014; 2: 167.
Browne TR, Adams RD, Robertson GH. Hemangioblastoma of the spinal cord. Review and report of five cases. Arch Neurol 1976; 33: 435-41.
Cervio A, Villalonga JF, Liñares JM, Mormandi R, Condomí-Alcorta S. Tratamiento quirúrgico de los hemangioblastomas del sistema nervioso central. Salvat Rev Argent Neuroc 2015; 29(3): 117-31.
Murota T, Symon L. Surgical management of hemangioblastoma of the spinal cord: a report of 18 cases. Neurosurgery 1998; 25: 699-708.
Lee DK, Choe WJ, Chung CK, Kim HJ. Spinal cord hemangioblastoma: surgical strategy and clinical outcome. J Neurooncol 2003; 61: 27-34.
Muscarella LA, Bisceglia M, Galliani CA, Zidar N, Ben-Dor DJ, Pasquinelli G, et al. Extraneuraxial hemangioblastoma: a clinicopathologic study of 10 cases with molecular analysis of the VHL gene. Pathol Res Pract 2018; 214(8): 1156-65.
Yasuda T, Hasegawa T, Yamato Y, Kobayashi S, Togawa D, Banno T, et al. Relationship between spinal hemangioblastoma location and age. Asian Spine J 2016; 10(2): 309-13.
Gelabert-González M. Hemangioblastomas de fosa posterior. Neurología 2007; 22(10): 853-9.
Gläsker S, Li J, Xia JB, Okamoto H, Zeng W, Lonser RR, et al. Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res 2006; 66: 4167-72.
Gurses I, Scheithauer BW. Inhibin-A immunoreactivity in nervous system lesions. Appl Immunohistochem Mol Morphol 2012; 20: 277-84.
Hoang MP, Amirkhan RH. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. Am J Surg Pathol 2003; 27: 1152-1156.
Ingold B, Wild PJ, Nocito A, Amin MB, Storz M, Heppner FL, et al. Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma. Histopathology 2008; 52: 674-81.
Tirabosco R, Mangham DC, Rosenberg AE, Vujovic S, Bousdras K, Pizzolitto S, et al. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol 2008; 32: 572-80.
Takei H, Powell SZ. Novel immunohistochemical markers in the diagnosis of nonglial tumors of nervous system. Adv Anat Pathol 2010; 17: 150-3.
Blaty D, Malos M, Palmrose T, McGirr S. Sporadic intradural extramedullary hemangioblastoma of the cauda equina: case report and literature review. World Neurosurg 2018; 109: 436-41.
Bamps S, Calenbergh FV, Vleeschouwer SD, Loon JV, Sciot R, Legius E, et al. What the neurosurgeon should know about hemangioblastoma, both sporadic and in von Hippel–Lindau disease: a literature review. Surg Neurol Int 2013;8(4): 145.
Tredway TL. Minimally invasive approaches for the treatment of intramedullary spinal tumors. Neurosurg Clin N Am 2014; 25: 327-36.
Snyder LA, Spetzler RF. Resection of sporadic spinal hemangioblastomas. World Neurosurg 2014; 82: 629-31.
Sun HI, Ozduman K, Usseli I, Ozgen S, Pamir MN. Sporadic spinal hemangioblastomas can be effectively treated by microsurgery alone. World Neurosurg 2014; 82: 836-47.
Kano H, Shuto T, Iwai Y, Sheehan J, Yamamoto M, McBride HL, et al. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study. J Neurosurg 2015; 122(6): 1469-78.
Li AY, Post AF, Dai JB, Choudhri TF. Spontaneous arrest of sporadic spinal hemangioblastoma growth after postoperative nodular recurrence: case report. Cureus 2018; 10(9): e3380.